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Abstract
In Alzheimer’s disease (AD), the severity of cognitive symptoms is better correlated with the levels of soluble amyloid-beta
(Ab) rather than with the deposition of fibrillar Ab in amyloid plaques. In APP/PS1 mice, a murine model of AD, at 8 months
of age the cerebellum is devoid of fibrillar Ab, but dosage of soluble Ab1–42, the form which is more prone to aggregation,
showed higher levels in this structure than in the forebrain. Aim of this study was to investigate the alterations of intrinsic
membrane properties and of synaptic inputs in Purkinje cells (PCs) of the cerebellum, where only soluble Ab is present. PCs
were recorded by whole-cell patch-clamp in cerebellar slices from wild-type and APP/PS1 mice. In APP/PS1 PCs, evoked
action potential discharge showed enhanced frequency adaptation and larger afterhyperpolarizations, indicating a
reduction of the intrinsic membrane excitability. In the miniature GABAergic postsynaptic currents, the largest events were
absent in APP/PS1 mice and the interspike intervals distribution was shifted to the left, but the mean amplitude and
frequency were normal. The ryanodine-sensitive multivescicular release was not altered and the postsynaptic
responsiveness to a GABAA agonist was intact. Climbing fiber postsynaptic currents were normal but their short-term
plasticity was reduced in a time window of 100–800 ms. Parallel fiber postsynaptic currents and their short-term plasticity
were normal. These results indicate that, in the cerebellar cortex, chronically elevated levels of soluble Ab1–42 are associated
with alterations of the intrinsic excitability of PCs and with alterations of the release of GABA from interneurons and of
glutamate from climbing fibers, while the release of glutamate from parallel fibers and all postsynaptic mechanisms are
preserved. Thus, soluble Ab1–42 causes, in PCs, multiple functional alterations, including an impairment of intrinsic
membrane properties and synapse-specific deficits, with differential consequences even in different subtypes of
glutamatergic synapses.
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Introduction
AD is a neurodegenerative disorder characterized by a
progressive decline in cognitive brain functions. The pathological
hallmarks of AD are parenchymal plaques containing Ab proteins
and intraneuronal neurofibrillary tangles. The hypothesis that Ab
aggregates play a causal role in AD [1] is supported by several
lines of evidence (reviewed in [2]). However, while in AD patients
the fibrillar plaque density is weakly correlated with the severity of
dementia and the extent of synaptic loss [3–4], these parameters
show a strong correlation with the levels of soluble aggregates of
Ab [5–7]. Soluble Ab has toxic effects on synaptic function and it
can readily diffuse in the extracellular spaces, as shown by the fact
that intracerebroventricular injections are effective in blocking
synaptic plasticity [8]. In this research we utilize a transgenic
murine model of AD, the APP/PS1 mouse [9], which bears a
marked forebrain amyloidosis while hindbrain structures, includ-
ing the cerebellum, are devoid of fibrillar Ab plaques. In APP/PS1
mice, the first amyloid plaques appear in the cerebral cortex at 6
weeks of age [9]. In hippocampus, amyloid deposition starts in the
dentate gyrus at 2–3 months of age and in CA1 at 4–5 months [9].
In striatum, thalamus and brain stem, amyloidosis appears
between 3 and 5 months of age [9]. At the age of 8 months the
entire forebrain is covered with amyloid [9], while in the
cerebellum no amyloid plaques are present (unpublished observa-
tions). In spite of the lack of amyloid deposits, the cerebellum of
APP/PS1 mice might be reached by significant levels of soluble Ab
via the extracellular spaces, as confirmed by the high amount of
soluble Ab1–42 observed in the present study. Actually, neurode-
generation in AD patients does not affect only the cerebrum but
also the cerebellum, although generally in later stages of the
disease. Many lines of research have shown that, in AD patients,
the cerebellum is reduced in volume in a similar fashion as
cerebral hemispheres [10–11], the Purkinje cell (PC) number is
decreased [12] and the levels of Ab1–42 are increased more than
twofold relative to controls [13].
The best characterized effects of soluble Ab on neuronal
function are exerted on glutamatergic synaptic transmission,
although with variable results in different experimental models
[8,14–18] (reviewed in [2]). In contrast to a decrease of network
activity predicted from the glutamatergic hypothesis, neuronal
hyperactivity has been reported in the hippocampal-entorhinal
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cortex network [19–21] and in cerebral cortex [22]. Such
hyperactivity has been attributed either to intrinsic hyperexcit-
ability [20–21] or to reduced inhibition [22]. Therefore, it is
important to simultaneously consider the effects of Ab on intrinsic
excitability, glutamatergic and GABAergic synaptic transmission.
In the present study, we investigated the alterations in intrinsic
excitability and synaptic transmission in the cerebellar PCs. We
show, in the cerebellar cortex of APP/PS1 mice, a reduction of
intrinsic membrane excitability of PCs and alterations of the
release of GABA from interneurons and of glutamate from CFs,
while the release of glutamate from PFs and all postsynaptic
mechanisms are preserved. These results indicate that, in the
cerebellar cortex, elevated levels of soluble Ab are associated with
alterations of the intrinsic excitability of PCs and of the function of
specific glutamatergic and GABAergic presynaptic terminals.
Results
Beta-amyloid levels in cerebellar extracellular fluids
The APP and PS1 transgenes of APP/PS1 mice are transcribed
under the control of the neuron-specific Thy1 promoter, which is
abundantly expressed in the forebrain but much less in the
cerebellum [9]. However, soluble forms of A are known to freely
diffuse in the extracellular fluids and distribute in all communi-
cating compartments, including adjacent regions like forebrain
and hindbrain. We performed ELISA assays in order to compare
the abundance of soluble Ab in the cerebellum relative to the
forebrain, where most of the transgene transcription occurs. At
two months of age, when amyloid plaque formation is still
negligible (Radde et al, 2006; and data not shown), the levels of
soluble Ab1–42 in the cerebellum were 51.2% when compared to
the forebrain (taken as 100%). At 8 months, which corresponds to
the age at which most of the results of the following experiments
were obtained, the cerebellar amount of soluble Ab1–42 increased
to 140.5% relative to the forebrain.
Intrinsic membrane properties and excitability of PCs
In cerebellar slices from mice of 7–8 months of age, the
spontaneous discharge of PCs was recorded immediately following
the achievement of the whole-cell configuration, before application
of synaptic blockers. The majority of PCs spontaneously fired
action potentials (12 out of 14 wild-type and 16 out 20 APP/PS1
cells). The mean firing frequency of PCs was 36.865.6 spikes/sec
for wild-type and 26.465.0/sec for APP/PS1, without a
significant difference (t-test, P.0.05).
Passive membrane properties of wild-type (n = 14 cells) and
APP/PS1 PCs (n= 20 cells) were assessed by delivering hyperpo-
larizing current steps in the presence of blockers of ionotropic
glutamate and GABAA receptors. The input resistance was
112.964.7 MV in wild-type and 109.463.6 MV in APP/PS1
PCs (Fig. 1A–B; Student’s t-test: P.0.05). In the responses to
hyperpolarizing steps, the amplitude of the bump due to the IH
inward rectifier current was 41.362.5 mV in wild-type and
40.461.8 mV in APP/PS1, with no significant difference (Fig. 1C–
D; Student’s t-test: P.0.05).
Membrane excitability and active membrane properties were
assessed by delivering, starting from a Vm close to 270 mV,
depolarizing current steps, which elicited repetitive firing in all
PCs of both groups of mice (Fig. 2A). The latency of the first spike
was highly variable and displayed a nonsignificant tendency to
longer values in APP/PS1 relative to wild-type PCs (MW test:
P.0.05, Fig. 2B). The first interspike interval was slightly
prolonged in APP/PS1 PCs, although the difference was not
significant (wild-type: 5.060.2; APP/PS1 6.560.1; Student’s
t-test: P.0.05, Fig. 2C). However, APP/PS1 PCs displayed
significantly prolonged second (wild-type: 8.060.9 ms; APP/PS1:
11.061.0 ms; Student’s t-test: P,0.05) and third (wild-type:
8.561.1 ms; APP/PS1: 11.761.1 ms; Student’s t-test: P,0.05)
interspike intervals, indicating a more pronounced frequency
adaptation (Fig. 2C).
The threshold and the amplitude of the first action potential
were comparable in PCs for both groups (Student’s t-test: P.0.05,
Fig. 3A–C). In contrast, the fast afterhyperpolarization (AHP)
following the first action potential was significantly larger in APP/
PS1 (18.661.4 mV) relative to wild-type PCs (14.461.8 mV; MW
test: P,0.025, Fig. 3D; representative traces are shown in panel
A). The distribution of AHP amplitudes was clearly shifted to
higher values in APP/PS1 mice (Fig. 3E), confirming an overall
tendency to larger AHPs.
In order to assess whether these alterations of membrane
excitability were due to the production of Ab rather than to some
other unspecific process, we have repeated the analyses on young
APP/PS1 (n = 10) and wild-type (n = 8) mice at the age of two
months. In fact, in two-months-old APP/PS1 mice there is no
significant amyloid formation or deposition (Radde et al., 2006;
and data not shown). The input resistance of PCs was
88.164.9 MV in wild-type and 93.464.9 MV in APP/PS1 mice
(P.0.05). In the responses to hyperpolarizing steps, the amplitude
of the bump due to the IH inward rectifier current was
47.663.0 mV in wild-type and 54.564.3 mV in APP/PS1, with
no significant difference (P.0.05).
In evoked action potential firing, the latency of the first spike
was highly similar, with 12.263.7 ms in wild type versus
12.062.7 ms in APP/PS1 (P.0.05). The first interspike interval
was 7.461.0 ms in wild-type and 8.260.7 in APP/PS1 (P.0.05).
More importantly, there was no significant difference in the
second interspike interval, with 9.561.2 ms in wild type and
11.762.0 in APP/PS1 PCs (P.0.05). The third interspike interval
could not be analyzed because some PCs fired only three action
potentials. The threshold and the amplitude of the first action
potential were very similar in PCs of both groups (P.0.05). The
fast afterhyperpolarization (AHP), which was significantly larger in
older APP/PS1 mice, in PCs of two-months-old mice had the
same amplitude as in age-matched wild type controls (wild type:
21.562.3; APP/PS1: 18.461.8; P.0.05). Therefore, no alter-
ations of membrane excitability were present in young adult mice
(2 months old), in which the production and deposition of Ab is
not yet significant. In contrast, PCs from older adult (7–8 months
old) APP/PS1 mice displayed a reduction of excitability
accompanied by an increased size of the AHP. Table 1 contains
a comprehensive list of all membrane parameters analyzed in wild-
type and APP/PS1 PCs
Functional analysis of GABAergic synapses onto PCs
Evoked inhibitory postsynaptic currents (eIPSCs), recorded in
PCs during block of ionotropic glutamate receptors, displayed no
significant difference between wild-type and APP/PS1 mice (wild-
type: 218.6641.8 pA, n= 10; APP/PS1: 250.8639.4 pA, n= 11;
P.0.05). Also the coefficient of variation (CV) and the value of
CV22 were not significantly different (P.0.05; Fig. 4). The
eIPSCs of both wild-type and APP/PS1 PCs were completely
blocked by application of a GABAA receptor antagonist (gabazine,
20 mM, data not shown).
Miniature inhibitory, GABAergic, currents (mIPSCs) were
isolated by the application of ionotropic glutamate receptor
blockers and TTX (Fig. 5 A–B). Under these conditions, the
residual miniature currents were completely abolished by gabazine
(data not shown). The mean amplitude of mIPSCs showed no
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significant difference between wild-type and APP/PS1 mice (wild-
type: 73.867.0 pA, n= 24; APP/PS1: 68.964.9 pA, n= 31;
Student’s t-test, P.0.05; Fig. 5C). The amplitude histograms
had a peak at 30–50 pA and were skewed, with a tail on the right,
representing the largest events (Fig. 5E–F). Such a tail was clearly
shorter in APP/PS1 PCs relative to wild-type, indicating that large
mIPSCs were underrepresented, as also shown by the cumulative
plot (Fig. 5G). The comparison of the cumulative distributions
(Fig. 5G) revealed a significant difference (KS test: P,0.001),
which can be attributed to the underrepresentation of the largest
events in APP/PS1 mice.
The mean frequency of mIPSCs was not different in the two
groups of mice (wild-type: 0.57860.080 Hz, n= 24; APP/PS1:
0.59560.086 Hz, n= 31; Fig. 5D). However, the comparison of
cumulative distributions for mIPSC interevent intervals revealed a
significant difference between the two groups (Fig. 5H, KS test,
Figure 2. Evoked firing properties of APP/PS1 PCs. (A) Wild-type (blue) and APP/PS1 (red) PC evoked action potential firing. In the wild-type
trace, the first three interspike intervals (ISI) are shown. (B) Mean latency of the first spike for PCs from wild-type (n = 14) and APP/PS1 (n = 20). The
difference is not significant (P.0.05). (C) Plot of the first three ISIs of wild-type (n = 14) and APP/PS1 (n = 20) mice PCs. The second and third ISIs are
significantly prolonged in APP/PS1 mice (*p,0.05, t test).
doi:10.1371/journal.pone.0034726.g002
Figure 1. Responses to hyperpolarizing currents. (A) Example of plots of peak amplitudes versus injected currents. Each point is the average of
five trials. Data were fitted by a linear function. Blue circles and lines: wild-type; red squares and lines: APP/PS1 (B) Mean input resistance values of
wild-type (blue column, n= 14) and APP/PS1 (red column, n = 20) PCs. There is no significant difference (P.0.05). (C) Example of plots of inward
rectification (IR) versus injected currents. Each point is the average of five trials. The line is the linear fitting. (D) Mean inward rectification of wild-type
and APP/PS1 PCs.
doi:10.1371/journal.pone.0034726.g001
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P,0.001), with shorter intervals in APP/PS1 PCs. Rise time and
decay kinetics of mIPSCs were not significantly different between
wild-type and APP/PS1 PCs (KS test: P.0.05 data not shown).
Presynaptic ryanodine receptors (RyRs) have been shown to be
involved in mIPSCs of PCs, where they are responsible for
multivescicular release, generating large amplitude events [23]. To
test whether the amplitude or frequency changes detected in APP/
PS1 PCs were attributable to an alteration of RyRs, we recorded
mIPSCs in the presence of ryanodine at a concentration (10 mM),
which evokes Ca2+ release from intracellular stores [23]. The
effects of ryanodine on mIPSCs were examined in n= 8 and
n=15 cells for wild-type and APP/PS1 mice respectively. Sample
histograms are shown in Fig. 6A–B. In wild-type mice, six cells
showed a significant (KS test: P,0.001; Fig. 6C, E) increase in
amplitude and frequency. Also for APP/PS1 mice, 13 cells showed
a significant (KS test: P,0.001; Fig. 6D, F) increase in frequency
and amplitude. The effect of ryanodine was comparable for the
two groups of animals both for amplitude (Fig. 6G; for wild-type
normalized mean amplitude relative to control 1.2060.10, n= 6;
for APP/PS1 1.1860.11, n = 13; Student’s paired t-test, P,0.01)
and frequency (Fig. 6H; for wild-type normalized mean frequency
relative to control 1.5760.09, n= 6; for APP/PS1 1.7160.30,
n = 13; Student’s paired t-test, P,0.01). These results confirm that
RyRs are functionally normal in APP/PS1 PCs.
In order to assess whether, at the interneuron-PC synapse,
postsynaptic alterations were also present, we monitored postsyn-
aptic currents evoked by bath applications of the GABAA receptor
agonist muscimol (0.5 mM). Comparable postsynaptic currents
were evoked by muscimol in wild-type and APP/PS1 PCs
(Fig. 7A–B; mean amplitude for wild-type 1.5260.14 nA,
n= 14; for APP/PS1 1.4860.18 nA, n= 14; Student’s t-test,
P.0.05). To test for a possible alteration of the desensitization
properties of the GABAA receptors, we applied muscimol again
10 minutes after the first application. The ratio between the two
applications was comparable (Fig. 7C; wild-type 0.7360.05,
n = 10; APP/PS1 0.7860.04, n= 11; Student’s t-test, P.0.05),
indicating that in APP/PS1 mice, PC GABAA receptors have
normal desensitization properties.
Evoked excitatory postsynaptic currents in PCs
The amplitude of CF-EPSCs showed no significant difference
between wild-type and APP/PS1 mice (Fig. 8A; wild-type:
0.9460.11 nA, n= 12; APP/PS1: 1.4960.50 nA, n= 10; Stu-
dent’s t-test, P.0.05). Short-term depression was analyzed by the
paired-pulse protocol at interpulse intervals ranging from 50 to
3200 ms. At intermediate intervals, between 100 and 800 ms,
APP/PS1 PCs displayed a reduced short-term depression relative
to wild-type (Fig. 8B; Student’s t-test, P,0.05). The time course of
short-term depression was described by double exponential
functions. APP/PS1 PCs, compared with wild-type, showed a
higher proportion and a shortening of the fast time constant (wild-
type: tf = 146.0 ms, 58.9%; APP/PS1: and tf = 125.8 ms, 69.3%),
in line with the smaller depression at relatively brief intervals.
EPSCs evoked by parallel fiber stimulation (PF-EPSCs) were
recorded at a VH of 290 mV. The stimulating electrode was
placed in a standard position in the middle of the molecular layer
between the PC soma and the pial surface. Parallel fibers were
stimulated with intensities ranging from 3 to 15 mA (Fig. 9A). The
PF-EPSC amplitudes, at any intensity of stimulation, showed no
significant difference between wild-type (n = 17 cells) and APP/
PS1 (n = 14 cells; Student’s t-test, P.0.05; Fig. 9B). Moreover, also
the time course of paired-pulse facilitation was similar in wild-type
and APP/PS1 PCs at all interpulse intervals (from 50 to 200 ms;
Student’s t-test, P.0.05; Fig. 9C). This result indicates that the PF-
PC synapse is not altered in APP/PS1 mice.
Table 2 contains a list of the main synaptic parameters analyzed
in wild-type and APP/PS1 PCs.
Discussion
In this study we show that, at the age of 7–8 months when
numerous amyloid plaques are present in the forebrain, the
Figure 3. Evoked action potential properties. (A) Superimposed traces of first action potentials of wild-type (blue) and APP/PS1 (red) PCs. The
horizontal dotted lines represent the threshold and the negative peaks reached by the afterhyperpolarization (AHP). The vertical arrows indicate the
measurements of spike amplitude (for both wild type and APP/PS1) and of the AHP (separately for wild-type and APP/PS1). (B) Mean action potential
threshold (P.0.05). (C) Mean amplitude of the first spike (P.0.05). (D) Mean AHP amplitude in wild-type (n = 14) and APP/PS1 PCs (n = 20). The
difference is statistically significant (*: p,0.05, t test). (E) Histogram of AHP sizes divided in four groups (,10, 10–20, 20–30, .30 mV). Note the shift
to the right of the distribution in APP/PS1 mice.
doi:10.1371/journal.pone.0034726.g003
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cerebellum of APP/PS1 mice contains high levels of soluble
Ab1–42, which are associated with a reduction of membrane
excitability of PCs and an altered GABAergic signaling.
Furthermore, we show a reduction of paired-pulse depression at
the CF-PC synapse. On the contrary, the function of the PF-PC
synapse is spared.
It has been widely suggested that soluble, rather than fibrillar,
Ab is the most important pathogenic factor in AD [24–25].
Actually, the presence of low picomolar concentrations of soluble
Ab1–42 are necessary to enable synaptic plasticity in the
hippocampus, but nanomolar doses impair hippocampal long-
term potentiation [26]. Moreover, it has been shown that
nanomolar doses of natural soluble oligomers of Ab obtained
from human cortex of AD patients are sufficient to induce
neuronal alterations [27]. APP/PS1 mice are a murine model of
AD, in which human mutated APPSwe and PS1L166P are produced
under the control of a promoter mainly expressed in the forebrain
[9]. However, soluble forms of Ab can freely diffuse in the
extracellular fluids and distribute in communicating compart-
ments, including adjacent regions like forebrain and hindbrain [8].
Indeed we found that the levels of soluble Ab1–42 in the cerebellum
of APP/PS1 mice of 2 months of age are about half relative to the
forebrain, but at 8 months the cerebellum contains about 40%
more soluble Ab1–42 than the forebrain. One possible explanation
is that in the forebrain, where at 8 months of age the formation of
amyloid plaques is massive, most of the Ab peptide produced is
being sequestered into plaques. In addition to the production of
Ab peptide, the high expression of the transgenes (the human
APPSwe transgene has an expression of about three times that of
endogenous mouse APP [9]) likely causes the generation of other
APP fragments, including sAPPa, sAPPb, AICD, CTFa, CTFb.
In this study the effects of these APP derivatives have not been
tested. For this reason, we cannot exclude that some of the
alterations described in this report are not due to Ab but to other
APP-derived fragments. However, since the transgenes are
predominantly expressed in the forebrain, any effect on the
cerebellar cortex should largely derive from diffusion between
these two regions. Although diffusion of other extracellular
fragments cannot be excluded, the most likely candidate for a
diffusion sufficient to account for the effects observed on PC
physiology is soluble Ab. Another possible cause of electrophys-
iological alterations is the expression of PS1L166P, which has been
shown to interfere with the release of Ca2+ from endoplasmic
reticulum stores [28]. Alterations of ryanodine-dependent calcium
release have been ruled out in our experiments on GABAergic
IPSCs, but we cannot exclude different contributions to the
control of membrane excitability.
Since PCs are the sole output of the cerebellar cortex, an
alteration of their firing properties can be sufficient to disrupt the
control on the target neurons in the deep cerebellar and vestibular
nuclei. In fact, changes in the pattern or frequency of firing of PCs
have important consequences also on the output from the deep
cerebellar nuclei [29]. In our study, the deficit of excitability of
PCs in the APP/PS1 mouse consists of a more pronounced
frequency adaptation, with interspike intervals, which tend to
increase in duration more than in control wild-type PCs. Such
alteration might be due to the larger amplitude of the AHP
following action potentials, because AHPs are known to be
involved in delaying the subsequent firing of action potentials. This
finding is in the same direction as the effect, in mouse dentate
gyrus, of the application of synthetic Ab1–42 oligomers, which in
one study caused a reduction of neuronal excitability [30]. A
second case, in which Ab1–42 production was associated with a
reduction of membrane excitability, was observed in 5XFAD
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mice, bearing 5 familial AD transgenes. In hippocampal CA1
pyramidal neurons of such 5XFAD mice, basal and learning-
related excitability was reduced relative to control mice [31].
However, in contrast to these results, several studies found
neuronal hyperexcitability in the hippocampal-entorhinal cortex
network [19–21].
GABAergic evoked and miniature IPSCs in APP/PS1 mice
have, on average, the same amplitude and frequency as in wild-
type. However, the distributions of mIPSC amplitudes and of ISIs
are significantly altered. In APP/PS1 mice, in the distribution
histograms, the largest amplitudes and the longest intervals are
underrepresented. An alteration of GABAergic signaling is in
accordance with recent evidence that a GABAergic impairment
may be important in the pathogenesis of network dysfunction in
AD [32]. In fact, AD patients have decreased GABA or
somatostatin levels in the brain and cerebrospinal fluid [32–37].
Furthermore, it has been recently reported that, in hAPP/PS1
mice, cerebral cortical neurons are hyperactive [22]. Such
hyperactivity is associated with decreased GABAergic inhibition
[22].
In cerebellar PCs, in addition to the classical role of voltage-
gated Ca2+ channels in neurotransmitter release, it has been shown
that the largest mIPSCs depend on a Ca2+-induced release of Ca2+
from intracellular stores [23]. Presenilin-1 mutations found in
FAD patients have profound effects on cellular Ca2+ homeostasis
[38–39]. The expression of FAD mutated presenilin, including the
L166P mutation of our APP/PS1 mice, disrupts Ca2+ leak from
intracellular Ca2+ stores [28], thereby causing an enhancement of
Ca2+ release. In our recordings, PCs from APP/PS1 mice do not
show an increase of large mIPSCs as expected by the effect of the
mutated presenilin, but they present the opposite phenomenon,
which is a reduction of large mIPCSs. However, in our
experiments ryanodine application produced the same effects in
APP/PS1 and wild-type PCs, indicating that the function of
ryanodine receptors of the endoplasmic reticulum of cerebellar
GABAergic interneurons was normal. The absence of the
enhancement of Ca2+ release, which would be expected from
the expression of PS1L166P, is in line with the fact that in our APP/
PS1 mice the expression of the transgenes is low in the cerebellum.
This finding strengthens the hypothesis that the functional
alterations described in this study are due to diffusion of soluble
factors like Ab or other secreted products of APPSwe from the
forebrain rather than to the expression of the transgenes by
cerebellar neurons.
Changes of the responsiveness of the postsynaptic membrane to
GABA are also unlikely because the distribution of mIPSCs is not
shifted and their mean amplitude is preserved in APP/PS1 mice. A
lack of involvement of postsynaptic GABAA receptors is confirmed
by the fact that the application of the GABAA agonist muscimol
produces similar effects in wild-type and APP/PS1 mice. Taken
together, our results on mIPSCs indicate that APP/PS1 mice have
alterations of the axonal mechanisms regulating the release of
GABA from cerebellar interneurons and that such defects are not
due to a different contribution of Ca2+ induced Ca2+ release from
ryanodine-sensitive intracellular stores.
In contrast to these alterations of the GABAergic synapses, the
glutamatergic synapses formed by PF and CF are relatively intact.
The transmission at the PF-PC synapse is completely normal,
suggesting that, in this synapse, both presynaptic boutons and
postsynaptic dendritic spines are functionally normal at qualitative
and also quantitative levels. The amplitude of the CF-evoked
EPSC was also normal, indicating that dendritic spines occupied
by climbing fiber varicosities are likely to be functionally normal.
The only functional alteration of glutamatergic synapses formed
on PCs was a reduction of the paired-pulse depression of CF-
EPSCs, which is considered as a presynaptic mechanism [40].
Figure 4. Evoked inhibitory post-synaptic currents (eIPSCs) in wild-type and APP/PS1 PCs. (A) Representative recordings of eIPSCs in
wild-type and (B) APP/PS1 mice. The number of superimposed traces is 65 in A and 70 in B. There is no significant difference (number of cells n = 10
for wild-type, n = 11 for APP/PS1; P.0.05) between the two groups in either the amplitude (C) or the coefficient of variation (D) or the CV22 (E).
doi:10.1371/journal.pone.0034726.g004
Cerebellar Functional Alterations in APP/PS1 Mice
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e34726
Figure 5. Miniature inhibitory post-synaptic currents (mIPSCs) in wild-type and APP/PS1 PCs. (A) Representative recordings of
spontaneous mIPSCs of a wild-type and (B) an APP/PS1 PC. Mean amplitude (C) and frequency (D) of mIPSCs (P.0.05 for both). (E) Amplitude
distribution of miniature GABAergic events in wild-type (n = 15 cells) and (F) APP/PS1 (n = 18 cells) mice. (G) Comparison of the cumulative
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distributions of amplitudes of the two groups. Note the selective loss of large amplitude mIPSCs in APP/PS1 PCs (***P,0.001, KS test). (H) Cumulative
frequency plot for inter-event intervals between the two groups (***P,0.001, KS test).
doi:10.1371/journal.pone.0034726.g005
Figure 6. Ryanodine effects on mIPSCs. (A) mIPSCs amplitude histograms obtained in control condition and in the presence of ryanodine for
wild-type (n = 6) and (B) for APP/PS1 (n = 13) cells. (C) Normalized cumulative amplitude histograms for wild-type and (D) for APP/PS1 cells
(***P,0.001, KS test). (E) Normalized cumulative frequency plot for inter-event intervals for wild-type and (F) APP/PS1 cells (***P,0.001, KS test). (G)
Ryanodine effect on the mIPSCs amplitude and (H) frequency for wild-type and APP/PS1 PCs. The effects of ryanodine relative to the controls before
application are significant (P,0.01, Student’s paired t-test) but no significant difference is present between genotypes.
doi:10.1371/journal.pone.0034726.g006
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Therefore, the release of glutamate from the CF is altered, so that
a second action potential in a time window between 100 and
800 ms is more efficient in APP/PS1 mice.
These alterations are likely to have complex consequences on
the cerebellar cortical network. In APP/PS1 mice, PCs are less
excitable, as they discharge fewer action potentials in response to
depolarizing stimuli. In addition, they present minor alterations of
the synapses formed by GABAergic interneurons and by CFs. The
lack of large mIPSCs might correspond to a less efficient inhibitory
action of stellate and basket cells on PCs. Indeed, a reduction of
GABAergic efficiency would favour excitation, rendering the cells
more easily driven towards threshold by excitatory inputs. In
addition to this reduced GABAergic function, in APP/PS1 PCs,
the excitatory CF-PC synapse is more powerful in a time window
of 100–800 ms from a previous complex spike. These two effects
could be additive, causing a tendency of APP/PS1 PCs to reach
action potential threshold more frequently. Along this line, the
decrease of intrinsic excitability could be envisioned as a
compensatory mechanism, aimed at re-establishing the physiolog-
ical rate of PC firing altered by the synaptic changes. However, at
present it not possible to exclude the opposite alternative, that the
synaptic alterations are compensatory for the impairment of
intrinsic excitability. Future experiments are necessary to deter-
mine whether one of the two events is primary and the other is
Figure 7. Responses to applications of muscimol. (A) Representative currents evoked by two applications of muscimol (0.5 mM), ten minutes
apart, in wild-type (blue) and APP/PS1 cells (red). (B) Mean amplitude of peak currents in wild-type and APP/PS1 cells evoked by the first application
of muscimol (P.0.05, Student’s t-test). (C) Ratio of the second current peak amplitude relative to the first one for both groups (P.0.05, Student’s t-
test).
doi:10.1371/journal.pone.0034726.g007
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compensatory. The concept of a reciprocal compensation of
membrane excitability and synaptic alterations is supported by the
fact that an extensive series of behavioral tests showed a conserved
motor performance and a lack of symptoms attributable to
cerebellar dysfunction (Material S1).
Materials and Methods
Ethics statement
The animal experimental procedures were approved by the
Bioethical Committee of the University of Turin (prot. 404 of June
Figure 8. CF-EPSCs in wild-type and APP/PS1 PCs. (A) Representative traces of postsynaptic currents evoked by climbing fiber paired-pulse
stimulation with an interpulse interval of 100 ms in wild-type (blue) and APP/PS1 (red) mice. (B) Time course of paired-pulse depression of CF-EPSC in
wild-type (blue circles, n = 12) and APP/PSl mice (red squares, n = 10). The lines are double exponentials fittings of wild-type and APP/PS1 data points.
The paired-pulse depression is expressed as the percentage of the amplitude of the second EPSC relative the first one (mean6 SEM) and is plotted as
a function of interpulse intervals. (*p,0.05; **p,0.01, Student’s t-test).
doi:10.1371/journal.pone.0034726.g008
Figure 9. PF-EPSCs in wild-type and APP/PS1 PCs. (A) Representative traces of PF-EPSCs evoked by paired-pulse stimulation with an interpulse
interval of 100 ms in wild-type (blue) and APP/PS1 (red) mice. Five traces obtained with stimulus strength from 3 to 15 mA are superimposed. (B)
Amplitudes of PF-EPSCs are plotted as a function of stimulus intensity for wild-type (blue circles, n = 14) and APP/PS1 (red squares, n = 17) PCs. (C)
Time course of paired-pulse facilitation of PF-EPSC in wild-type (blue circles, n = 17) and APP/PSl mice (red squares, n = 14). The facilitation is
expressed as the percentage of the second EPSC relative to the first one (mean 6 SEM) and is plotted as a function of interstimulus interval.
doi:10.1371/journal.pone.0034726.g009
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17, 2005), have been communicated to the Ministry of Health
(January 12, 2005 and October 21, 2008) and are in accordance
with the European Union Directives 86/609/EEC and 6106/10/
EU.
Animals
Seven to eight months old APP/PS1 transgenic mice (n = 37)
and their wild-type littermates (n = 35) of male gender were used
for all the experimental paradigms. Evoked action potentials were
studied also in 2 months old APP/PS1 mice (n = 3) and their wild-
type littermates (n = 3). The APP/PS1 double transgenic mice
(genetic background C57BL/6J) express mutated PS1 (PS1L166P)
and APP (APPSwe, harboring the double KM670/671NL
mutation) both under the control of a neuron-specific Thy1
promoter element [9]. Transgenic mice were obtained from Dr.
Mathias Jucker, Hertie-Institute for Clinical Brain Research,
University of Tu¨bingen (Germany).
Ab ELISA
Total proteins of cerebella and forebrains from 2, and 8 month
old mice (n = 3 for each age group) were extracted in Tris-buffered
saline [150 mM NaCl, 50 mM Tris base, pH 8, 1% Triton X-100,
protease inhibitor cocktail (Sigma Aldrich)] at 1 ml buffer/150 mg
wet weight tissue. After centrifugation (25 min at 13,000 rpm at
4uC), the supernatant was used to measure soluble Ab produced
under the action of the human transgenes. The levels of soluble
Ab1–42 were quantified using the Innotest Ab amyloid 1–42 high
sensitivity test-ELISA kit (Innogenetics, Belgium). The kit uses an
antibody that does not recognize mouse endogenous Ab. Ab1–42
levels were standardized to brain tissue weight and expressed as
the ratio of the value in the cerebellum relative to the forebrain.
The levels of soluble Ab1–42, measured in serum from the same
animals, were stable between the two ages analyzed and close to
blank values.
Slice preparation
Cerebellar slices were prepared as previously described [41].
The animals were anesthetized with isoflurane (Isoflurane-Vet,
Merial, Italy) and decapitated. The cerebellar vermis was removed
and transferred to an ice-cold artificial cerebrospinal fluid (ACSF)
containing (in mM); 125 NaCl, 2.5 KCl, 2 CaCl2, 1 MgCl2, 1.25
NaH2PO4, 26 NaHCO3, 20 glucose, which was bubbled with
95% O2/5% CO2 (pH 7.4). Parasagittal cerebellar slices (200 mm
thickness) were obtained using a vibratome (Leica Microsystems
GmbH, Wetzlar, Germany) and kept for 1 h at 35uC and then at
25uC. Single slices were placed in the recording chamber, which
was perfused at a rate of 2–3 ml/min with ACSF bubbled with the
95% O2/5% CO2. All recordings were performed at room
temperature (22–25uC). Data of each experimental paradigm
derive from 3 to 5 animals.
Electrophysiology
Whole-cell patch-clamp recordings were made from PCs of
adult animals using an EPC-9 patch-clamp amplifier (HEKA
Elektronik, Lambrecht/Pfalz, Germany). Recordings were accept-
ed only if the series resistance was less than 9.0 MV (range: 5.0–
9.0 MV), and if it did not vary by .20% during the experiment.
The soma of PCs was visually identified using a 406 water-
immersion objective of an upright microscope (E600FN, Eclipse,
Nikon, Japan), and its upper surface was cleaned by a glass pipette,
pulled from sodalime glass to a tip diameter of 10–15 mm,
containing the saline solution. Pipettes of borosilicate glass with
resistances between 2.5 and 3.0 MV were used for patch-clamp
T
a
b
le
2
.
C
o
m
p
ar
is
o
n
o
f
sy
n
ap
ti
c
p
ar
am
e
te
rs
o
f
w
ild
-t
yp
e
ve
rs
u
s
A
P
P
/P
S1
m
ic
e
o
f
8
m
o
n
th
s
o
f
ag
e
.
e
v
o
k
e
d
IP
S
C
a
m
p
li
tu
d
e
(p
A
)
e
v
o
k
e
d
IP
S
C
C
V
e
v
o
k
e
d
IP
S
C
C
V
2
2
m
in
ia
tu
re
IP
S
C
a
m
p
li
tu
d
e
(p
A
)
m
in
ia
tu
re
IP
S
C
fr
e
q
u
e
n
cy
(H
z
)
M
u
sc
im
o
l-
e
v
o
k
e
d
cu
rr
e
n
t
(n
A
)
C
F
_
E
P
S
C
a
m
p
li
tu
d
e
(n
A
)
C
F
-E
P
S
C
P
P
D
a
t
2
0
0
m
s
(%
)
P
F
_
E
P
S
C
a
m
p
li
tu
d
e
a
t
9
mA
(p
A
)
W
ild
-t
yp
e
8
m
o
n
th
s
2
1
8
.6
6
4
1
.8
n
=
1
0
0
.4
8
6
0
.0
6
n
=
1
0
6
.8
2
6
1
.6
5
n
=
1
0
7
3
.8
6
7
.0
n
=
2
4
0
.5
8
6
0
.0
8
n
=
2
4
1
.5
2
6
0
.1
4
n
=
1
4
0
.9
4
6
0
.1
1
n
=
1
2
7
9
.1
6
0
.9
n
=
1
2
3
1
8
.8
6
4
8
.5
n
=
1
7
A
P
P
/P
S1
8
m
o
n
th
s
2
5
0
.8
6
3
9
.4
n
=
1
1
0
.4
2
6
0
.0
3
n
=
1
1
7
.0
4
6
1
.5
6
n
=
1
1
6
8
.9
6
4
.9
n
=
3
1
0
.6
0
6
0
.0
9
n
=
3
1
1
.4
8
6
0
.1
8
n
=
1
4
1
.4
9
6
0
.5
0
n
=
1
0
8
3
.0
6
0
.7
n
=
1
0
3
6
1
.5
6
3
4
.8
n
=
1
4
Si
n
g
le
d
at
a
p
o
in
ts
P
(S
tu
d
e
n
t’
s
t
te
st
)
n
.s
.
n
.s
.
n
.s
.
n
.s
.
n
.s
.
n
.s
.
n
.s
.
,
0
.0
1
n
.s
.
C
u
m
u
la
ti
ve
d
is
tr
ib
u
ti
o
n
P
(K
o
lm
o
g
o
ro
v-
Sm
ir
n
o
v
te
st
)
-
-
-
,
0
.0
0
1
,
0
.0
0
1
-
-
-
-
d
o
i:1
0
.1
3
7
1
/j
o
u
rn
al
.p
o
n
e
.0
0
3
4
7
2
6
.t
0
0
2
Cerebellar Functional Alterations in APP/PS1 Mice
PLoS ONE | www.plosone.org 11 April 2012 | Volume 7 | Issue 4 | e34726
recording. Patch pipettes were filled with an internal solution
containing (in mM): 130 CsCl, 4 MgCl2, 10 HEPES, 4 Na2ATP,
0.4 Na3GTP, 10 EGTA, 5 N-(2,6-dimethylphenyl)acetamide-2-
triethylammonium bromide (QX-314) and the pH was adjusted to
7.3 with CsOH and filtered at 0.2 mm. Cs+ blocks most outward
currents through K+ channels while QX-314 blocks voltage-gated
Na+ channels. Data were filtered at 3 kHz and sampled at 10 kHz.
For all the experiments, digitized data were stored on a Macintosh
computer (G3, Apple computer, Cupertino, CA, USA) using the
Patch Master software (HEKA Elektronik, Lambrecht/Pfalz,
Germany) and analyzed off-line.
Current clamp recordings. For current clamp recordings
patch pipettes were filled with a K-gluconate-based internal
solution containing (in mM); 140 K-gluconate, 10 HEPES, 0.5
EGTA, 4 MgCl2, 4 Na2ATP, 0.4 Na3GTP and the pH was
adjusted to 7.3 with KOH and filtered at 0.2 mm. Gabazine (SR
95531, 20 mm) and kynurenic acid (1 mM) were added to the
perfusate to inhibit the GABAA and ionotropic glutamate
receptors of PCs. Recordings were performed after manually
adjusting the holding current at a value, which kept the membrane
voltage close to 270 mV (61 mV). Neurons in which the holding
current was greater than 400 pA were discarded. Data were
filtered at 8.6 kHz and sampled at 20 kHz. A series of current
steps, each lasting 1000 ms, was delivered to the PC. Such current
steps ranged from 2400 to +1000 pA, in increments of 100 pA,
with a step interval of 10 s. Data were analyzed using Axograph
software (AxoGraph Scientific, Sydney, Australia) and afterwards
the data were collected in a Microsoft Excel (Microsoft
Corporation, Bellevue, WA, USA) spreadsheet.
Passive membrane properties characterization. In order
to analyze the input resistance and the voltage bump due to the
inward rectifier cationic current (IH), we measured the input
resistance from the maximal negative deflections from the
baseline, evoked by hyperpolarizing current steps ranging from
2400 to2100 pA (five traces were measured for each point) while
the amplitude of the voltage bump was measured as the difference
between the peak negative deflection and the stable voltage level
reached during the hyperpolarizing current step [42]. Such values
were plotted as a function of the intensity of the respective
hyperpolarizing currents, and the slope of the best fitting
regression line was taken for each cell.
Active membrane properties characterization. Single
action potential (AP) features were analyzed on traces evoked by
the delivery to the PCs of a current step of +600 pA. All
parameters of each cell were measured in five traces and averaged.
The analyzed action potential properties were: threshold, AP
amplitude, AP afterhyperpolarization (AHP), interspike interval
(ISI). ISI was defined as the distance between the peaks of two
consecutive APs. Threshold was measured in the first derivative of
the AP (dV/dt) considering the point where the velocity was
closest to 50 mV/ms. AP amplitude was measured as the voltage
difference between the threshold and the absolute value reached at
the peak. AHP amplitude was calculated as the voltage difference
between the threshold and the negative AHP peak. Post–burst
AHP (PB-AHP) was analyzed in responses to current steps of
+1000 pA and it was calculated as the voltage difference between
the baseline before the depolarizing step and the negative
deflection after the action potential burst.
Responses of PCs to climbing fiber (CF) stimulation. To
evoke excitatory postsynaptic currents (EPSCs) derived from CF
(CF–EPSCs) inputs onto PCs, square pulses (100 ms) were applied
through a stimulating electrode placed in the granular layer. CF-
EPSCs were recorded at a holding potential of +40 mV to avoid
the problems related to the large size of CF-evoked synaptic
currents at negative potentials. CF-EPSCs were identified by their
all-or-none fashion and the presence of paired pulse depression
[43–44]. When the threshold was detected, the paired pulse
depression was elicited by twin pulses at different time intervals
(50, 100, 150, 200, 400, 800, 1600, 3200 ms). All CF recordings
were performed in the presence of the GABAA antagonist
gabazine (SR 95531, 20 mM) in the saline solution.
Responses of PCs to parallel fiber (PF) stimulation (PF-
EPSCs). PF-EPSCs were evoked by stimulating the PFs in the
molecular layer and recorded at a holding potential of 290 mV,
to exploit the advantages of a larger distance from the reversal
potential to obtain a better resolution of PF-evoked currents, and
of keeping the voltage far from the threshold for most voltage-
dependent conductances. Negative current pulses ranging from 3
to 15 mA with a duration of 100 ms were delivered at 20 s interval.
Paired pulse facilitation was elicited by twin pulses of 9 mA of
intensity at different time intervals (50, 100, 150, 200 ms), and the
ratio of the amplitude of the second PF-EPSC over the first was
calculated. All PF recordings were performed in the presence of
gabazine (SR 95531, 20 mm) in the saline solution.
Inhibitory postsynaptic currents (IPSCs). Miniature
IPSCs (mIPSC) were recorded from PCs at a holding potential
of 270 mV in the presence of the glutamate antagonists D- (-) –2-
amino–phosphonopentanoic acid (D-AP5, 10 mm) and NBQX
(20 mm), and of tetrodotoxin (TTX; 1 mm). The analysis of
spontaneous and miniature events was performed with Mini
Analysis software (Synaptosoft Inc., Decatur, GA, USA). mIPSCs
with amplitudes ,5 pA were discarded. Events with 10–90% rise
times greater than 2 ms were also discarded. Mean mIPSC
frequency and amplitude values were determined from at least
three consecutive epochs of 50 s. Cumulative frequency plots were
constructed by integrating the distribution histograms of mIPSC
amplitudes and inter-event intervals.
Drugs
Gabazine was purchased from Sigma Chemical (St. Louis, MO,
USA). D-AP5, NBQX, kynurenic acid, muscimol and TTX were
purchased from Tocris Cookson (Langford, UK). Ryanodine was
purchased from Ascent Scientific Ltd (Bristol, UK). All drugs were
applied via the chamber perfusion line.
Statistics
Data are presented as mean value 6 SEM. Unless otherwise
indicated, n =number of cells. For data which passed the
normality test, the statistical comparison was performed either
by the paired or the unpaired two tailed Student’s t-test. Data for
which the normality test failed, were compared by the Mann-
Whitney u-test. Cumulative frequency plots were analyzed by
Kolmogorov-Smirnov (KS) test. All the graphs were designed
using Igor Pro (WaveMetrics, Lake Oswego, Oregon, USA), and
statistical tests were performed by means of SPSS software (SPSS
Inc., Chicago, IL, USA). P values lesser than 0.05 was accepted as
significant.
Supporting Information
Material S1 Wild-type and APP/PS1 mice were subject-
ed to a set of motor tests. In fixed bar test, footprinting test
and beam test, there was no significant difference between the two
groups. In the accelerated rotarod test there was no significant
difference either for the initial performance or for the improve-
ment over three consecutive days or for the retention test seven
days later.
(DOC)
Cerebellar Functional Alterations in APP/PS1 Mice
PLoS ONE | www.plosone.org 12 April 2012 | Volume 7 | Issue 4 | e34726
Acknowledgments
Dr. Arianna Sala and Dr. Antonio Betolotto are gratefully acknowledged
for the execution of the ELISA assay. The technical support of Mr. Matteo
Novello is acknowledged. The authors have no actual or potential conflicts
of interest to disclose.
Author Contributions
Conceived and designed the experiments: EH FT. Performed the
experiments: EH EB FM. Analyzed the data: EH EB FM RP. Wrote the
paper: EH FT.
References
1. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease:
progress and problems on the road to therapeutics. Science 297: 353–356.
2. Ashe KH, Zahs KR (2010) Probing the biology of Alzheimer’s disease in mice.
Neuron 66: 631–645.
3. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, et al. (1991) Physical
basis of cognitive alterations in Alzheimer’s disease: synapse loss is the major
correlate of cognitive impairment. Ann Neurol 30: 572–580.
4. Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, et al. (1995)
Correlations of synaptic and pathological markers with cognition of the elderly.
Neurobiol Aging 16: 285–298.
5. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, et al. (1999) Soluble amyloid
beta peptide concentration as a predictor of synaptic change in Alzheimer’s
disease. Am J Pathol 155: 853–862.
6. McLean CA, Cherny RA, Fraser FW, Fuller SJ, Smith MJ, et al. (1999) Soluble
pool of Abeta amyloid as a determinant of severity of neurodegeneration in
Alzheimer’s disease. Ann Neurol 46: 860–866.
7. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration:
lessons from the Alzheimer’s amyloid beta-peptide. Nat Rev Mol Cell Biol 8:
101–112.
8. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, et al. (2002)
Naturally secreted oligomers of amyloid beta protein potently inhibit
hippocampal long-term potentiation in vivo. Nature 416: 535–539.
9. Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, et al. (2006)
Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust
pathology. EMBO Rep 7: 940–946.
10. Bas O, Acer N, Mas N, Karabekir HS, Kusbeci OY, et al. (2009) Stereological
evaluation of the volume and volume fraction of intracranial structures in
magnetic resonance images of patients with Alzheimer’s disease. Ann Anat 191:
186–195.
11. Raji CA, Lopez OL, Kuller LH, Carmichael OT, Becker JT (2009) Age,
Alzheimer disease, and brain structure. Neurology 73: 1899–1905.
12. Mavroudis IA, Fotiou DF, Adipepe LF, Manani MG, Njau SD, et al. (2010)
Morphological changes of the human purkinje cells and deposition of neuritic
plaques and neurofibrillary tangles on the cerebellar cortex of Alzheimer’s
disease. Am J Alzheimers Dis Other Demen 25: 585–591.
13. Hashimoto M, Bogdanovic N, Volkmann I, Aoki M, Winblad B, et al. (2010)
Analysis of microdissected human neurons by a sensitive ELISA reveals a
correlation between elevated intracellular concentrations of Abeta42 and
Alzheimer’s disease neuropathology. Acta Neuropathol 119: 543–554.
14. Hsia AY, Masliah E, McConlogue L, Yu GQ, Tatsuno G, et al. (1999) Plaque-
independent disruption of neural circuits in Alzheimer’s disease mouse models.
Proc Natl Acad Sci U S A 96: 3228–3233.
15. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, et al. (2003) APP
processing and synaptic function. Neuron 37: 925–937.
16. Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ (2006) Effects of
secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a
potent role for trimers. J Physiol 572: 477–492.
17. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, et al. (2008)
Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair
synaptic plasticity and memory. Nat Med 14: 837–842.
18. Wei W, Nguyen LN, Kessels HW, Hagiwara H, Sisodia S, et al. (2010) Amyloid
beta from axons and dendrites reduces local spine number and plasticity. Nat
Neurosci 13: 190–196.
19. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, et al. (2007) Aberrant
excitatory neuronal activity and compensatory remodeling of inhibitory
hippocampal circuits in mouse models of Alzheimer’s disease. Neuron 55:
697–711.
20. Minkeviciene R, Rheims S, Dobszay MB, Zilberter M, Hartikainen J, et al.
(2009) Amyloid beta-induced neuronal hyperexcitability triggers progressive
epilepsy. J Neurosci 29: 3453–3462.
21. Harris JA, Devidze N, Verret L, Ho K, Halabisky B, et al. (2010) Transsynaptic
progression of amyloid-beta-induced neuronal dysfunction within the entorh-
inal-hippocampal network. Neuron 68: 428–441.
22. Busche MA, Eichhoff G, Adelsberger H, Abramowski D, Wiederhold KH, et al.
(2008) Clusters of hyperactive neurons near amyloid plaques in a mouse model
of Alzheimer’s disease. Science 321: 1686–1689.
23. Llano I, Gonzalez J, Caputo C, Lai FA, Blayney LM, et al. (2000) Presynaptic
calcium stores underlie large-amplitude miniature IPSCs and spontaneous
calcium transients. Nat Neurosci 3: 1256–1265.
24. Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, et al. (2002)
Immunization reverses memory deficits without reducing brain Abeta burden in
Alzheimer’s disease model. Nat Neurosci 5: 452–457.
25. Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure
in Alzheimer’s disease. Neuron 44: 181–193.
26. Puzzo D, Privitera L, Leznik E, Fa` M, Staniszewski A, et al. (2008) Picomolar
amyloid-beta positively modulates synaptic plasticity and memory in hippocam-
pus. J Neurosci 28: 14537–14545.
27. Jin M, Shepardson N, Yang T, Chen G, Walsh D, et al. (2011) Soluble amyloid
beta-protein dimers isolated from Alzheimer cortex directly induce Tau
hyperphosphorylation and neuritic degeneration. Proc Natl Acad Sci U S A
108: 5819–5824.
28. Nelson O, Tu H, Lei T, Bentahir M, de Strooper B, et al. (2007) Familial
Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of
presenilin 1. J Clin Invest 117: 1230–1239.
29. McKay BE, Molineux ML, Mehaffey WH, Turner RW (2005) Kv1 K+ channels
control Purkinje cell output to facilitate postsynaptic rebound discharge in deep
cerebellar neurons. J Neurosci 25: 1481–1492.
30. Yun SH, Gamkrelidze G, Stine WB, Sullivan PM, Pasternak JF, et al. (2006)
Amyloid-beta1–42 reduces neuronal excitability in mouse dentate gyrus.
Neurosci Lett 403: 162–165.
31. Kaczorowski CC, Sametsky E, Shah S, Vassar R, Disterhoft JF (2011)
Mechanisms underlying basal and learning-related intrinsic excitability in a
mouse model of Alzheimer’s disease. Neurobiol Aging 32: 1452–1465.
32. Palop JJ, Mucke L (2010) Amyloid-beta-induced neuronal dysfunction in
Alzheimer’s disease: from synapses toward neural networks. Nat Neurosci 13:
812–818.
33. Davies P, Katzman R, Terry RD (1980) Reduced somatostatin-like immuno-
reactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer
senile dementa. Nature 288: 279–280.
34. Bareggi SR, Franceschi M, Bonini L, Zecca L, Smirne S (1982) Decreased CSF
concentrations of homovanillic acid and gamma-aminobutyric acid in
Alzheimer’s disease. Age- or disease-related modifications? Arch Neurol 39:
709–712.
35. Zimmer R, Teelken AW, Trieling WB, Weber W, Weihmayr T, et al. (1984)
Gamma-aminobutyric acid and homovanillic acid concentration in the
CSF of patients with senile dementia of Alzheimer’s type. Arch Neurol 41:
602–604.
36. Hardy J, Cowburn R, Barton A, Reynolds G, Dodd P, et al. (1987) A disorder of
cortical GABAergic innervation in Alzheimer’s disease. Neurosci Lett 73:
192–196.
37. Seidl R, Cairns N, Singewald N, Kaehler ST, Lubec G (2001) Differences
between GABA levels in Alzheimer’s disease and Down syndrome with
Alzheimer-like neuropathology. Naunyn Schmiedebergs Arch Pharmacol 363:
139–145.
38. Bezprozvanny I, Mattson MP (2008) Neuronal calcium mishandling and the
pathogenesis of Alzheimer’s disease. Trends Neurosci 31: 454–463.
39. Green KN, LaFerla FM (2008) Linking calcium to Abeta and Alzheimer’s
disease. Neuron 59: 190–194.
40. Hashimoto K, Kano M (1998) Presynaptic origin of paired-pulse depression at
climbing fibre-Purkinje cell synapses in the rat cerebellum. J Physiol 506(Pt 2):
391–405.
41. Sacco T, De Luca A, Tempia F (2006) Properties and expression of Kv3
channels in cerebellar Purkinje cells. Mol Cell Neurosci 33: 170–179.
42. Williams SR, Christensen SR, Stuart GJ, Hausser M (2002) Membrane potential
bistability is controlled by the hyperpolarization-activated current I(H) in rat
cerebellar Purkinje neurons in vitro. J Physiol 539: 469–483.
43. Konnerth A, Llano I, Armstrong CM (1990) Synaptic currents in cerebellar
Purkinje cells. Proc Natl Acad Sci U S A 87: 2662–2665.
44. Perkel DJ, Hestrin S, Sah P, Nicoll RA (1990) Excitatory synaptic currents in
Purkinje cells. Proc Biol Sci 241: 116–121.
Cerebellar Functional Alterations in APP/PS1 Mice
PLoS ONE | www.plosone.org 13 April 2012 | Volume 7 | Issue 4 | e34726
